A carregar...
Direct oral anticoagulant use and risk of severe COVID‐19
BACKGROUND: Hypercoagulability and thromboembolism are prominent features of severe COVID‐19, and ongoing anticoagulant use might be protective. METHODS: We conducted a nationwide register‐based cohort study in Sweden, February through May, 2020, to assess whether ongoing direct oral anticoagulant (...
Na minha lista:
| Publicado no: | J Intern Med |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7753564/ https://ncbi.nlm.nih.gov/pubmed/33258156 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/joim.13205 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|